Your browser is no longer supported. Please, upgrade your browser.
Collegium Pharmaceutical, Inc.
Index- P/E6.83 EPS (ttm)2.65 Insider Own1.70% Shs Outstand35.37M Perf Week1.68%
Market Cap620.25M Forward P/E4.15 EPS next Y4.36 Insider Trans-0.97% Shs Float34.10M Perf Month-6.89%
Income103.50M PEG12.42 EPS next Q1.04 Inst Own- Short Float10.16% Perf Quarter-15.13%
Sales325.80M P/S1.90 EPS this Y212.10% Inst Trans0.24% Short Ratio11.88 Perf Half Y-26.82%
Book/sh7.10 P/B2.55 EPS next Y16.93% ROA15.10% Target Price25.00 Perf Year-24.75%
Cash/sh5.64 P/C3.21 EPS next 5Y0.55% ROE48.10% 52W Range17.22 - 26.91 Perf YTD-3.00%
Dividend- P/FCF7.13 EPS past 5Y17.10% ROI12.50% 52W High-32.66% Beta0.98
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin60.20% 52W Low5.23% ATR0.67
Employees234 Current Ratio1.40 Sales Q/Q-0.50% Oper. Margin20.50% RSI (14)44.51 Volatility4.46% 3.46%
OptionableYes Debt/Eq1.04 EPS Q/Q-21.00% Profit Margin31.80% Rel Volume0.89 Prev Close18.08
ShortableYes LT Debt/Eq0.85 EarningsNov 04 AMC Payout0.00% Avg Volume291.65K Price18.12
Recom2.10 SMA20-3.36% SMA50-2.90% SMA200-14.22% Volume260,540 Change0.22%
Aug-06-21Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-11-21Reiterated H.C. Wainwright Buy $29 → $33
Jul-14-20Initiated BWS Financial Sell $8
May-27-20Initiated Guggenheim Neutral
Feb-19-20Resumed Jefferies Buy $43
Oct-30-19Reiterated Needham Buy $33 → $25
May-03-19Resumed H.C. Wainwright Buy $23
Apr-12-19Resumed Janney Buy $29
Mar-20-19Initiated SunTrust Hold $22
Jan-16-19Reiterated Needham Buy $35 → $33
Mar-08-18Reiterated H.C. Wainwright Buy $21 → $33
Feb-07-18Reiterated Needham Buy $28 → $35
Dec-05-17Reiterated Needham Buy $25 → $28
Sep-11-17Initiated H.C. Wainwright Buy $21
May-11-17Reiterated Needham Buy $28 → $25
Sep-13-16Initiated Gabelli & Co Buy $25
Jun-01-15Initiated Piper Jaffray Overweight $26
Jun-01-15Initiated Needham Buy $28
Jun-01-15Initiated Jefferies Buy $20
Jan-12-22 07:09PM  
Jan-04-22 04:51AM  
Dec-29-21 05:00AM  
Dec-28-21 08:00AM  
Dec-06-21 01:42PM  
Nov-17-21 03:01AM  
Nov-15-21 08:30AM  
Nov-11-21 04:54PM  
Nov-05-21 12:00PM  
Nov-04-21 08:56PM  
Nov-02-21 08:39AM  
Oct-28-21 03:05PM  
Oct-21-21 04:01PM  
Oct-15-21 08:49AM  
Sep-28-21 08:24AM  
Sep-20-21 11:40AM  
Sep-13-21 08:00AM  
Sep-01-21 04:01PM  
Aug-16-21 08:00AM  
Aug-06-21 09:00AM  
Aug-05-21 06:25PM  
Aug-04-21 03:06AM  
Jul-29-21 03:04PM  
Jun-16-21 04:01PM  
Jun-02-21 01:00PM  
May-20-21 04:05PM  
May-06-21 08:31PM  
Apr-29-21 05:03PM  
Apr-15-21 04:01PM  
Feb-26-21 08:01AM  
Feb-25-21 04:01PM  
Feb-24-21 10:27AM  
Feb-11-21 04:01PM  
Feb-09-21 06:31PM  
Feb-08-21 06:49PM  
Jan-06-21 04:01PM  
Dec-16-20 05:48PM  
Nov-07-20 08:36AM  
Nov-06-20 10:31PM  
Nov-05-20 05:45PM  
Oct-29-20 12:35PM  
Oct-26-20 08:00AM  
Oct-25-20 07:05AM  
Oct-22-20 04:01PM  
Oct-12-20 01:25PM  
Oct-04-20 06:51AM  
Sep-30-20 08:00AM  
Sep-25-20 08:00AM  
Sep-14-20 08:00AM  
Sep-09-20 04:05PM  
Aug-07-20 11:39AM  
Aug-05-20 07:15PM  
Aug-04-20 12:04PM  
Aug-03-20 12:59PM  
Jul-29-20 12:33PM  
Jul-21-20 05:00PM  
Jul-07-20 11:40AM  
Jun-19-20 11:40AM  
Jun-17-20 05:09PM  
Jun-03-20 11:40AM  
May-27-20 08:44AM  
May-18-20 11:40AM  
May-13-20 11:06AM  
May-08-20 12:31PM  
May-07-20 04:01PM  
Apr-30-20 12:34PM  
Apr-23-20 04:01PM  
Apr-07-20 04:01PM  
Apr-06-20 09:30AM  
Apr-01-20 08:50AM  
Mar-26-20 11:40AM  
Mar-24-20 05:03AM  
Mar-20-20 07:44AM  
Mar-10-20 11:40AM  
Feb-27-20 04:01PM  
Feb-26-20 01:05PM  
Feb-20-20 12:31PM  
Feb-13-20 04:01PM  
Feb-10-20 07:15PM  
Feb-08-20 07:04AM  
Feb-07-20 07:32AM  
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dreyer ScottEVP & Chief Commercial OfficerDec 15Sale18.335,693104,35376,970Dec 17 04:33 PM
Ciaffoni JosephPresident and CEOJun 02Sale22.815,861133,689267,774Jun 03 04:16 PM
Ciaffoni JosephPresident and CEOJun 01Option Exercise8.2216,205133,205289,840Jun 03 04:16 PM
Ciaffoni JosephPresident and CEOJun 01Sale23.2016,205375,912273,635Jun 03 04:16 PM
Kuhlmann Shirley R.EVP and General CounselMay 10Sale22.777,000159,39089,990May 12 04:06 PM
Heffernan Michael ThomasDirectorMar 15Sale25.3050,0751,266,7744,047Mar 17 04:03 PM
Ciaffoni JosephPresident and CEOMar 01Option Exercise8.2248,616399,624343,075Mar 03 08:02 PM
Ciaffoni JosephPresident and CEOMar 01Sale22.6764,7681,468,425278,307Mar 03 08:02 PM
Fleming Alison BChief Technical OfficerMar 01Sale23.366,011140,417148,753Mar 03 08:01 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 11Sale25.217,898199,13283,258Feb 12 04:16 PM